Published in J Pediatr Endocrinol Metab on October 10, 2001
Thyroid volume and urinary iodine excretion in schoolchildren in North-Eastern Bosnia. Eur J Pediatr (2004) 0.75
Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol (1992) 2.08
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst (2001) 1.82
Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol (1999) 1.70
Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol (1998) 1.60
Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord (2000) 1.31
Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol (1996) 1.19
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol (1994) 1.04
Doctor in the house: trends in GPs home visiting in Croatia 1990-1995 compared to current trends in USA and UK. Coll Antropol (1997) 1.03
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol (1995) 0.99
Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol (1993) 0.99
Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer (1994) 0.95
Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J Clin Oncol (1991) 0.95
p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res (1998) 0.93
Endovascular treatment of superior vena cava obstruction in patients with malignancies. Eur Radiol (1999) 0.91
Trauma- and stressor related disorders in the tuareg refugees of a cAMP in burkina faso. Clin Pract Epidemiol Ment Health (2013) 0.91
Future development of biologically relevant dosimetry. Br J Radiol (2014) 0.90
SPM nanolithography of hydroxy-silicates. Nanotechnology (2012) 0.90
p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer (1994) 0.89
Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res (1999) 0.89
Fistulectomy and sphincteric reconstruction for complex cryptoglandular fistulas. Colorectal Dis (2009) 0.88
Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma. Lab Invest (1996) 0.86
A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies. Appl Radiat Isot (2009) 0.85
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. Clin Cancer Res (1999) 0.85
E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis. Hum Pathol (2004) 0.85
Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes. Am J Clin Pathol (1992) 0.84
Microdosimetric investigation at the therapeutic proton beam facility of CATANA. Radiat Prot Dosimetry (2004) 0.82
Analysis of genetic and cultural conservation value of three indigenous Croatian cattle breeds in a local and global context. J Anim Breed Genet (2010) 0.82
Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone in juvenile obesity before and after hypocaloric diet. J Endocrinol Invest (1995) 0.81
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas. Am J Pathol (1997) 0.80
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française. Ann Oncol (1997) 0.80
Light and nitrate interaction in phytochrome-controlled germination ofPaulownia tomentosa seeds. Planta (1990) 0.80
NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas. Hum Pathol (2000) 0.80
[Atropine poisoning. Importance of the clinical diagnosis]. Minerva Anestesiol (1998) 0.79
Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med (1997) 0.78
Towards the final BSA modeling for the accelerator-driven BNCT facility at INFN LNL. Appl Radiat Isot (2011) 0.78
[Propofol-ketamine vs propofol-fentanyl in short gynecologic surgery]. Minerva Anestesiol (1990) 0.78
Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma. Eur J Cancer (1994) 0.78
[The effect of GH on erythropoiesis in vivo]. Minerva Endocrinol (1993) 0.77
[Respiratory infection and bronchial cancer]. Rev Mal Respir (1992) 0.77
Impact of socioeconomic status on health-related quality of life in children with type 1 diabetes mellitus in Bosnia and Herzegovina. Minerva Pediatr (2013) 0.76
[Hepatotoxicity of cyclosporine in patients with kidney transplants]. Med Arh (1999) 0.76
Study of a solid state microdosemeter based on a monolithic silicon telescope: irradiations with low-energy neutrons and direct comparison with a cylindrical TEPC. Radiat Prot Dosimetry (2010) 0.76
Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome. Clin Endocrinol (Oxf) (1998) 0.76
[Knemometry in the assessment of short term effects of growth hormone therapy in children with several growth disorders]. Minerva Pediatr (1997) 0.76
[Relationship between blood insulin and arterial hypertension in obese adults]. Minerva Med (1991) 0.75
Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine. Int J Radiat Oncol Biol Phys (1998) 0.75
[Comparative analysis of the studies of irregularities during the period of fifteen years]. Stomatol Vjesn (1986) 0.75
[Epidemiology of childhood obesity: prevalence in North-West Italy]. Minerva Pediatr (1996) 0.75
[Serum angiotensin converting enzyme activity in patients with chronic renal insufficiency]. Med Arh (1987) 0.75
The STARTRACK experiment. Radiat Prot Dosimetry (2007) 0.75
[Flap surgery and subgingival curettage in the treatment of alveolar pockets - comparative study]. Stomatol Vjesn (1983) 0.75
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer. Semin Oncol (1994) 0.75
[Angiotensin converting enzyme activity in the brain and plasma after acute hemorrhage]. Med Arh (1986) 0.75
[Primary pulmonary malignant fibrohistiocytoma. Apropos of a case]. Rev Pneumol Clin (1987) 0.75
[Cavitary images and dysphonia in a young woman]. Rev Pneumol Clin (1995) 0.75
[Iatrogenic factors in periodontal diseases due to inadequate removable construction]. Stomatol Vjesn (1978) 0.75
[Percutaneous treatment of superior vena cava obstruction]. Rev Mal Respir (1999) 0.75
Track nanodosimetry of 20-MeV protons at 20 nm. Radiat Prot Dosimetry (2010) 0.75
[Our experiences in the surgical treatment of periodontal diseases with a special review on flap-surgery]. Stomatol Vjesn (1980) 0.75
Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients. AJR Am J Roentgenol (1995) 0.75
[Angiotensin converting enzyme activity in parts of the brain, hypophysis and adrenal gland of rabbits one hour after posthemorrhagic hypotension]. Srp Arh Celok Lek (1987) 0.75
Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung. Lung Cancer (2001) 0.75
[Respective roles of the products of the mdr1 and p53 genes in drug resistance of bronchial cancers]. Bull Cancer (1994) 0.75
[Serum kininase I activity in experimental diabetes]. Srp Arh Celok Lek (1987) 0.75
[Patient motivation in maintaining oral hygiene as an important factor in the preservation of gingival health]. Stomatol Vjesn (1980) 0.75
Effect of a 3-week body mass reduction program on body composition, muscle function and motor performance in pubertal obese boys and girls. J Endocrinol Invest (2004) 0.75
Controlled positive and negative surface charge injection and erasure in a GaAs/AlGaAs based microdevice by scanning probe microscopy. Nanotechnology (2008) 0.75
[Angiotensin-converting enzyme activity after physical exertion]. Med Arh (1984) 0.75
[Evaluation of monitoring the efficacy of phenobarbital as an anticonvulsant agents using the fluorescence-polarization immunoassay]. Med Arh (1998) 0.75
[Iodine deficiency in the Federation of Bosnia and Herzegovina]. Med Arh (2000) 0.75
A solid state microdosimeter based on a monolithic silicon telescope. Radiat Prot Dosimetry (2006) 0.75
A case of tropical pulmonary eosinophilia. Clin Infect Dis (1994) 0.75
[Serum cyclosporine levels in patients after kidney transplantation]. Med Arh (1998) 0.75
[Angiotensin converting enzyme activity in the blood of dogs with posthemorrhagic hypotension]. Acta Med Iugosl (1989) 0.75
[Clinical significance of a study of T and B lymphocytes in children with systemic lupus erythematosus and chronic juvenile arthritis]. Med Arh (1985) 0.75
[Angiotensin-converting enzyme activity in (some) endocrine glands in man, rabbits, and rats]. Srp Arh Celok Lek (1987) 0.75
Development of a hip joint model for finite volume simulations. J Biomech Eng (2014) 0.75
[Cushing syndrome and small cell carcinoma. Three case reports]. Rev Mal Respir (1997) 0.75
[Angiotensin converting enzyme activity in the tissue of the carotid arteries and pulmonary arteries in man and animals]. Med Arh (1987) 0.75
Microdosimetric assessment of the radiation quality of a therapeutic proton beam: comparison between numerical simulation and experimental measurements. Radiat Prot Dosimetry (2010) 0.75
[Effect of sex on the increase of GH induced by galanin, alone or in combination with GHRH with or without pyridostigmine in pubescent subjects]. Minerva Endocrinol (1996) 0.75
[Postoperative left ventricular function in patients with transposition of the great blood vessels]. Med Arh (2000) 0.75
Dexfentluramine in the treatment of juvenile obesity. Minerva Pediatr (1997) 0.75
[Multicenter pediatric therapeutic interventional heart catheterization 1996-1998]. Med Arh (1999) 0.75
[Tuberculosis as a cause of transient serous meningitis in children]. Plucne Bolesti Tuberk (1975) 0.75
Note: radiofrequency scanning probe microscopy using vertically oriented cantilevers. Rev Sci Instrum (2012) 0.75
Development of mapped stress-field boundary conditions based on a Hill-type muscle model. Int J Numer Method Biomed Eng (2014) 0.75
[Serum angiotensin-converting enzyme activity in disorders of thyroid gland function--clinical and experimental findings]. Srp Arh Celok Lek (1985) 0.75